Envestnet Portfolio Solutions Inc. Sells 335 Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Envestnet Portfolio Solutions Inc. cut its stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 6.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 4,707 shares of the company’s stock after selling 335 shares during the quarter. Envestnet Portfolio Solutions Inc.’s holdings in Acadia Healthcare were worth $366,000 as of its most recent SEC filing.

Other institutional investors also recently bought and sold shares of the company. Fifth Third Bancorp lifted its position in shares of Acadia Healthcare by 25.5% during the fourth quarter. Fifth Third Bancorp now owns 670 shares of the company’s stock worth $52,000 after purchasing an additional 136 shares during the last quarter. Tranquility Partners LLC lifted its position in shares of Acadia Healthcare by 5.3% during the fourth quarter. Tranquility Partners LLC now owns 3,395 shares of the company’s stock worth $264,000 after purchasing an additional 170 shares during the last quarter. GAMMA Investing LLC bought a new stake in shares of Acadia Healthcare during the fourth quarter worth $26,000. Arizona State Retirement System raised its holdings in shares of Acadia Healthcare by 1.3% in the third quarter. Arizona State Retirement System now owns 26,205 shares of the company’s stock valued at $1,842,000 after acquiring an additional 349 shares in the last quarter. Finally, Headlands Technologies LLC bought a new stake in shares of Acadia Healthcare in the third quarter valued at about $25,000.

Wall Street Analysts Forecast Growth

ACHC has been the subject of several recent research reports. Cantor Fitzgerald restated a “neutral” rating and issued a $90.00 price objective on shares of Acadia Healthcare in a report on Tuesday, March 5th. Bank of America decreased their price objective on Acadia Healthcare from $105.00 to $90.00 and set a “buy” rating for the company in a report on Thursday, May 2nd. UBS Group lifted their price objective on Acadia Healthcare from $88.00 to $102.00 and gave the company a “buy” rating in a report on Wednesday, February 28th. TheStreet upgraded Acadia Healthcare from a “c” rating to a “b-” rating in a report on Monday, March 4th. Finally, Royal Bank of Canada restated an “outperform” rating and issued a $94.00 price objective on shares of Acadia Healthcare in a report on Wednesday. One investment analyst has rated the stock with a sell rating, three have given a hold rating and six have given a buy rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $87.56.

Insider Transactions at Acadia Healthcare

In other news, Director Wade D. Miquelon sold 2,203 shares of the business’s stock in a transaction dated Tuesday, March 5th. The stock was sold at an average price of $85.39, for a total transaction of $188,114.17. Following the sale, the director now owns 46,074 shares in the company, valued at $3,934,258.86. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 2.00% of the company’s stock.

Acadia Healthcare Price Performance

ACHC opened at $64.25 on Friday. Acadia Healthcare Company, Inc. has a 1 year low of $63.75 and a 1 year high of $87.77. The firm has a market capitalization of $5.96 billion, a PE ratio of -458.90, a price-to-earnings-growth ratio of 1.95 and a beta of 1.31. The company has a debt-to-equity ratio of 0.63, a current ratio of 1.27 and a quick ratio of 1.27. The business’s 50-day moving average is $72.54 and its two-hundred day moving average is $76.89.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings results on Thursday, May 2nd. The company reported $0.84 earnings per share for the quarter, topping analysts’ consensus estimates of $0.80 by $0.04. Acadia Healthcare had a positive return on equity of 11.49% and a negative net margin of 0.38%. The business had revenue of $768.10 million for the quarter, compared to analyst estimates of $779.20 million. During the same quarter in the previous year, the firm earned $0.75 earnings per share. The company’s revenue was up 9.1% on a year-over-year basis. Research analysts anticipate that Acadia Healthcare Company, Inc. will post 3.53 earnings per share for the current fiscal year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.